Effects of pioglitazone treatment on postprandial lipid metabolism in type 2 diabetes

被引：0
|
作者：
Al Majali, K [1 ]
Cooper, M [1 ]
Adiseshiah, M [1 ]
Hurel, S [1 ]
Harry, P [1 ]
Urquhart, R [1 ]
Betteridge, DJ [1 ]
机构：
[1] UCL Royal Free & Univ Coll Med Sch, Middlesex Hosp, London, England
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2003年 / 4卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(03)90560-5
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：130 / 131
页数：2
相关论文
共 50 条
  • [31] The effect of sensitisation to insulin with pioglitazone on fasting and postprandial lipid metabolism, lipoprotein modification by lipases, and lipid transfer activities in type 2 diabetic patients
    K. Al Majali
    M. B. Cooper
    B. Staels
    G. Luc
    M-R. Taskinen
    D. J. Betteridge
    [J]. Diabetologia, 2006, 49 : 527 - 537
  • [32] Comparison of the effects of nateglinide and glibenclamide on postprandial glucose and lipid fluxes in Type 2 diabetes
    Dimitriadis, G
    Boutati, E
    Lambadiari, V
    Mitrou, P
    Maratou, E
    Houssianakou, E
    Raptis, S
    [J]. DIABETOLOGIA, 2002, 45 : A245 - A245
  • [33] Effects of physiological vs non-physiological restoration of postprandial insulin secretion on glucose and lipid metabolism in type 2 diabetes
    Lambadiari, V.
    Dimitriadis, G.
    Boutati, E.
    Mitrou, P.
    Maratou, E.
    Raptis, S. A.
    [J]. DIABETOLOGIA, 2006, 49 : 341 - 342
  • [34] Relation between the effect of Pioglitazone treatment on glucose-lipid metabolism, blood pressure and abdominal fat distribution in type 2 diabetes
    Maruyama, H
    Terauchi, M
    Hayashi, K
    Yamamoto, Y
    Ishii, T
    Saruta, T
    [J]. DIABETES, 2001, 50 : A125 - A125
  • [35] Pioglitazone is effective in the treatment of patients with type 2 diabetes
    Schneider, R
    Lessem, J
    Lekich, R
    [J]. DIABETES, 1999, 48 : A109 - A109
  • [36] Actos (pioglitazone): a new treatment for type 2 diabetes
    Lawrence, JM
    Reckless, JPD
    [J]. HOSPITAL MEDICINE, 2001, 62 (07): : 411 - 416
  • [37] REVISITING THE USE OF PIOGLITAZONE IN THE TREATMENT OF TYPE 2 DIABETES
    Einhorn, Daniel
    Fonseca, Vivian
    [J]. ENDOCRINE PRACTICE, 2016, 22 (11) : 1343 - 1346
  • [38] Risk management in the treatment of type 2 diabetes with pioglitazone
    Derosa, Giuseppe
    Salvadeo, Sibilla A. T.
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 51 - 60
  • [39] Loss of premenopausal advantage in postprandial lipid metabolism in type 2 diabetes is due to abnormal chylomicron clearance
    Masding, MG
    Stears, AJ
    Wootton, S
    Sandeman, DD
    [J]. DIABETES, 2002, 51 : A19 - A20
  • [40] The benefits of oestrogens on postprandial lipid metabolism are lost in post-menopausal women with Type 2 diabetes
    Masding, MG
    Stears, AJ
    Burdge, GC
    Wootton, SA
    Sandeman, DD
    [J]. DIABETIC MEDICINE, 2006, 23 (07) : 768 - 774
12345